CVS HEALTH CORP (CVS) Institutional Ownership Changes & 13F Activity
CVS HEALTH CORP (CVS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Dodge & Cox Stock Fund, Hancock Classic Value, Ariel Appreciation Fund, Renaissance Technologies LLC, and Sequoia Financial Advisors.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2020 | Vulcan Value Partners | Sell | -1,373,177 | 5,308,715 | $314,966 |
| Q1 2020 | Renaissance Technologies LLC | Buy | 1,258,200 | 1,271,253 | $75,423 |
| Q1 2020 | Dodge & Cox Stock Fund | Buy | 368,385 | 20,863,956 | $1,237,859 |
| Q1 2020 | Hancock Classic Value | Buy | 163,186 | 1,114,976 | $66,152 |
| Q1 2020 | Matrix Advisors Value Fund | Buy | 28,778 | 328,865 | $19,512 |
| Q1 2020 | Torray Fund | Buy | 26,596 | 26,596 | $1,578 |
| Q1 2020 | Olstein Capital Management | Buy | 19,500 | 144,000 | $8,544 |
| Q1 2020 | Matrix Private Capital Group | Buy | 14,035 | 14,035 | $833 |
| Q1 2020 | Sequoia Financial Advisors | Buy | 566 | 5,299 | $314 |
| Q1 2020 | Hillman Value Fund | Sell | -286 | 70,920 | $4,208 |
| Q4 2019 | Vulcan Value Partners | Sell | -2,073,020 | 6,681,892 | $496,398 |
| Q4 2019 | Renaissance Technologies LLC | Sell | -386,215 | 13,053 | $970 |
| Q4 2019 | Dodge & Cox Stock Fund | Sell | -357,601 | 20,495,571 | $1,522,616 |
| Q4 2019 | Parnassus Endeavor Fund | Buy | 111,538 | 8,372,832 | $622,017 |
| Q4 2019 | Hillman Value Fund | Buy | 71,206 | 71,206 | $5,290 |
| Q4 2019 | Olstein Capital Management | Sell | -61,800 | 124,500 | $9,249 |
| Q4 2019 | Muhlenkamp & Co | Buy | 36,479 | 106,514 | $7,913 |
| Q4 2019 | Fairfax Financial Holdings | Buy | 26,500 | 26,500 | $1,968 |
| Q4 2019 | Matrix Advisors Value Fund | Buy | 22,178 | 300,087 | $22,293 |
| Q4 2019 | Sequoia Financial Advisors | Buy | 662 | 4,733 | $352 |
| Q4 2019 | Miller Value Partners | Sell | -350 | 759,225 | $56,403 |
| Q4 2019 | Hancock Classic Value | Sell | -132 | 951,790 | $70,708 |
| Q4 2019 | Mairs & Power Growth Fund | Buy | 130 | 2,873 | $213 |
| Q3 2019 | Parnassus Endeavor Fund | Buy | 1,020,904 | 8,261,294 | $521,040 |
| Q3 2019 | Hancock Classic Value | Buy | 236,189 | 951,922 | $60,038 |
| Q3 2019 | Renaissance Technologies LLC | Buy | 196,615 | 399,268 | $25,182 |
| Q3 2019 | Vulcan Value Partners | Sell | -171,719 | 8,754,912 | $552,172 |
| Q3 2019 | Dodge & Cox Stock Fund | Buy | 162,868 | 20,853,172 | $1,315,210 |
| Q3 2019 | Muhlenkamp & Co | Buy | 70,035 | 70,035 | $4,417 |
| Q3 2019 | Matrix Advisors Value Fund | Buy | 27,742 | 277,909 | $17,528 |
Frequently asked questions about CVS activity
Which institutional owners are buying CVS?
Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CVS activity?
"Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CVS increasing?
Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CVS Institutional Insights
- CVS Institutional Ownership Overview
- CVS Institutional Ownership & Insiders Activity
- CVS Institutional Ownership & 13F Activity
- CVS Top Institutional Shareholders
- CVS Institutional Buying Activity
- CVS Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CVS Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings